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 Division of Gynecologic Oncology  
 
  
The Gynecologic Oncology Division at 
the University of Iowa consists of four 
attending physicians, three fellows-in-
training, two physician assistants, three 
nurses and supporting research and 
clerical staff. The concentration of our 
division remains the care of women with 
gynecologic malignancies. Our service 
area includes all counties of Iowa as 
well as western Illinois. Our patients are 
seen and treated in the National Cancer 
Institute designated Holden 
Comprehensive Cancer Center on the 
University of Iowa Hospitals campus.  
 
The clinical work of our division includes 
surgery, chemotherapy and radiation 
therapy treatments. A current initiative of 
the division is minimally invasive surgery 
in women with uterine cancers. This has 
been led by Dr. David Bender who 
developed the robotic surgery program. 
The division currently averages five 
procedures a week in women with 
gynecologic malignancies. A review of 
patient outcomes being assembled for 
publication has found significant 
decreases in patient length of stay and 
postoperative complications with the use 
of robotic surgery.  
 
The division continues its long-standing 
commitment to research through 
participation in clinical trials as well as a 
laboratory research initiative by Dr. 
Michael Goodheart. The division has 
been a member of the Gynecologic 
Oncology Group since shortly after its 
inception and continues to actively 
participate in trials. Our division was 
recently recognized as one of the five 
highest accruing sites among all GOG 
institutions. Dr. Goodheart is in the 
midst of a research training grant from 
the National Institutes of Health that 
allows him to divide his time between 
the clinic and laboratory and he was 
also  recognized for his work with a 
three-year, $1.5 million grant award 
from the ARRA program.  
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